📊 Score Breakdown
Offering Ability
40
Cash Runway
10
Float Risk
10
Warrant Exposure
15
Convertible Debt—
🌦️ Dilution Forecast
☀️
Clear
No significant dilution signals
7%
🔄 Reverse Split
15%
• 52-week low $0.75 has breached $1
💹 Market Data
Market Cap$19.40M
Shares Outstanding16.33M
Float16.33M
Cash$26.91M
Debt$1.59M
Short InterestN/A
🏛 Institutional Holdings
QoQ: ↓ 94.4% shares (2025Q4 vs prior)
2 institutional holders · 242 shares
#1
UBS Group AG
240 shares
#2
MORGAN STANLEY
2 shares
📉 Short Interest
Short Interest4.7K
Days to Cover1.0
% of Float0.0%
FINRA data as of Apr 30, 2026
📁 Recent SEC Activity
No recent SEC insights
📰 Recent News
No recent news
🔬 More Research for LICN
📊 LICN FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 LICN Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.